CG Oncology (CGON) Equity Average (2024 - 2025)

Historic Equity Average for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $679.0 million.

  • CG Oncology's Equity Average rose 2468.69% to $679.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $679.0 million, marking a year-over-year increase of 2468.69%. This contributed to the annual value of $305.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CG Oncology reported Equity Average of $679.0 million as of Q3 2025, which was up 2468.69% from $687.6 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Equity Average ranged from a high of $719.1 million in Q1 2025 and a low of $222.9 million during Q1 2024